127 related articles for article (PubMed ID: 8078900)
1. Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation.
France LL; Piatti PG; Newman JF; Toth I; Gibbons WA; Brown F
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8442-6. PubMed ID: 8078900
[TBL] [Abstract][Full Text] [Related]
2. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site. Structural basis for its antigenic cross-reactivity with the parent peptide.
Petit MC; Benkirane N; Guichard G; Du AP; Marraud M; Cung MT; Briand JP; Muller S
J Biol Chem; 1999 Feb; 274(6):3686-92. PubMed ID: 9920919
[TBL] [Abstract][Full Text] [Related]
4. Correlations between the conformations elucidated by CD spectroscopy and the antigenic properties of four peptides of the foot-and-mouth disease virus.
Siligardi G; Drake AF; Mascagni P; Rowlands D; Brown F; Gibbons WA
Eur J Biochem; 1991 Aug; 199(3):545-51. PubMed ID: 1651235
[TBL] [Abstract][Full Text] [Related]
5. A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide.
Siligardi G; Drake AF; Mascagni P; Rowlands DJ; Brown F; Gibbons WA
Int J Pept Protein Res; 1991 Dec; 38(6):519-27. PubMed ID: 1726426
[TBL] [Abstract][Full Text] [Related]
6. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
Sobrino F; Martinez MA; Carrillo C; Beck E
Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
[TBL] [Abstract][Full Text] [Related]
7. Conformational study of a nine residue fragment of the antigenic loop of foot-and-mouth disease virus.
Vega MC; Aleman C; Giralt E; Perez JJ
J Biomol Struct Dyn; 1992 Aug; 10(1):1-13. PubMed ID: 1329841
[TBL] [Abstract][Full Text] [Related]
8. Two mechanisms of antigenic diversification of foot-and-mouth disease virus.
Martínez MA; Hernández J; Piccone ME; Palma EL; Domingo E; Knowles N; Mateu MG
Virology; 1991 Oct; 184(2):695-706. PubMed ID: 1653494
[TBL] [Abstract][Full Text] [Related]
9. Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4.
Blanco E; McCullough K; Summerfield A; Fiorini J; Andreu D; Chiva C; Borrás E; Barnett P; Sobrino F
J Virol; 2000 May; 74(10):4902-7. PubMed ID: 10775633
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona.
Gomes P; Giralt E; Andreu D
Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711
[TBL] [Abstract][Full Text] [Related]
11. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E
J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204
[TBL] [Abstract][Full Text] [Related]
12. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
13. The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions.
Rowlands D; Logan D; Abu-Ghazaleh R; Blakemore W; Curry S; Jackson T; King A; Lea S; Lewis R; Newman J
Arch Virol Suppl; 1994; 9():51-8. PubMed ID: 8032279
[TBL] [Abstract][Full Text] [Related]
14. [Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus].
Rar VA; Makarov EA; Iurovskiĭ VV; Meshcheriakova EA; Andronova TM; Ivanov VT
Bioorg Khim; 1990 Jul; 16(7):904-15. PubMed ID: 2173604
[TBL] [Abstract][Full Text] [Related]
15. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site.
Feigelstock D; Mateu MG; Piccone ME; De Simone F; Brocchi E; Domingo E; Palma EL
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3307-11. PubMed ID: 1335031
[TBL] [Abstract][Full Text] [Related]
16. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
17. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
[TBL] [Abstract][Full Text] [Related]
18. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
Tulasiram P; Suryanarayana V
Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.
Domingo E; Verdaguer N; Ochoa WF; Ruiz-Jarabo CM; Sevilla N; Baranowski E; Mateu MG; Fita I
Virus Res; 1999 Aug; 62(2):169-75. PubMed ID: 10507326
[TBL] [Abstract][Full Text] [Related]
20. Display-induced antigenic variation in recombinant peptides.
Carbonell X; Feliu JX; Benito A; Villaverde A
Biochem Biophys Res Commun; 1998 Jul; 248(3):773-7. PubMed ID: 9704003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
